Loading organizations...
The Mayo Benefactors Innovation Fund, an integral component of the Mayo Clinic's Center for Clinical and Translational Science, builds and sustains medical research through dedicated financial awards. It provides essential funding streams designed to support the development and progression of researchers, enabling them to pursue novel ideas and translate scientific discoveries into clinical applications. The fund primarily offers grants for early-career and mid-career faculty, fostering projects across a spectrum of medical disciplines.
This initiative originates from the philanthropic vision of Mayo Clinic's benefactors, whose collective contributions form the bedrock of these innovation awards. Established as a mechanism to channel donor support directly into research, the fund addresses the critical need for sustained investment in scientific inquiry. It recognizes that pioneering medical breakthroughs often require foundational support at various stages of a researcher's career, from initial concept development to advanced project execution.
The fund's primary beneficiaries are Mayo Clinic researchers, including junior and established faculty, who are actively engaged in clinical and translational science. By providing crucial financial resources, the Mayo Benefactors Innovation Fund empowers these scientists to accelerate their investigations, ultimately contributing to advancements in patient care and global health. Its long-term vision centers on cultivating a vibrant research ecosystem that continually pushes the boundaries of medical knowledge and therapeutic solutions.
Mayo Benefactors Innovation Fund has 2 tracked investments across 2 companies. The latest tracked deal is $15.0M Series A in Cadence Neuroscience in October 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2019 | Cadence Neuroscience | $15.0M Series A | JAZZ Venture Partners | The General Partnership, Sonya Dumanis, Mayo Clinic |
| Jan 24, 2013 | Labdoor | $350K Seed | — | Aberdare Ventures, Kleiner Perkins, Mohr Davidow Ventures |